The Medical Advisor

Abstract Butyrate, a short-chain fatty acid (SCFA) produced via bacterial fermentation of dietary fiber in the colon, has emerged as a critical modulator of gut health, immune regulation, and neurocognitive function. This review explores the metabolic, immunological, and neurological roles of butyrate, examining its mechanisms of action and implications for chronic disease prevention. Current evidence underscores the necessity of dietary and lifestyle interventions to enhance butyrate production and optimize overall health outcomes. Introduction Butyrate, one of the principal SCFAs generated by gut microbiota, plays a fundamental role in maintaining colonic homeostasis, regulating immune responses, and supporting neural function. Recent studies have emphasized its influence on metabolic pathways, immune modulation, and the gut-brain axis. Understanding butyrate’s diverse physiological roles is essential for advancing therapeutic strategies targeting gut dysbiosis, inflammatory disorder...

Dr. Thomas N. Seyfried, PhD, Professor of Biology at Boston College, has been singing the praises of an ancestral diet for treating the modern disease of cancer for years… and with good reason. His theory that cancer is a metabolic disease sounds almost too simplistic, and yet makes perfect sense when you understand what drives cancer’s growth. Standard of Care: The Cut, Poison and Burn Method and Its Miserable Success Record Seyfried is not a fan of conventional medical cancer treatments. As he states in his groundbreaking book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer, the majority of today’s health care practitioners are required to prescribe conventional cancer treatments like chemotherapy and radiation—despite their toxicity and the possibility that they encourage new tumor growth. In fact, if a physician does not include these modalities in a treatment plan, the physician may be at risk of losing his medical ...